Literature DB >> 5471831

Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7S-gamma-2 antibody.

T S Orr, J Gwilliam, J S Cox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5471831      PMCID： PMC1455674     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  14 in total

1.  Cutaneous antigen-antibody reactions in the rat.

Authors:  W E BROCKLEHURST; J H HUMPHREY; W L PERRY
Journal:  J Physiol       Date:  1960-03       Impact factor: 5.182

2.  The role of histamine in cutaneous antigen-antibody reactions in the rat.

Authors:  W E BROCKLEHURST; J H HUMPHREY; W L PERRY
Journal:  J Physiol       Date:  1955-08-29       Impact factor: 5.182

3.  Role of PMN-leukocyte lyosomes in tissue injury, inflammation and hypersensitivity. 3. Passive cutaneous anaphylaxis induced in the rat with homologous and heterologous hyperimmune antibody.

Authors:  C A Lovett; H Z Movat
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

4.  Haemorrhagic reactions elicited at sites of passive cutaneous anaphylaxis by the intravenous injection of aggregated gamma-globulin.

Authors:  O G Bier; H C Passos; M Siqueira
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

5.  Biologic properties of rat antibodies. 3. Histamine release mediated by two classes of antibodies.

Authors:  H C Morse; K F Austen; K J Bloch
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

6.  Mites and house-dust allergy.

Authors:  J Pepys; M Chan; F E Hargreave
Journal:  Lancet       Date:  1968-06-15       Impact factor: 79.321

7.  Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung.

Authors:  P Sheard; A M Blair
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

8.  Rat 7S immunoglobulins: characterization of gamma-2- and gamma-1-anti-haptens antibodies.

Authors:  V E Jones
Journal:  Immunology       Date:  1969-05       Impact factor: 7.397

9.  Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.

Authors:  J S Cox
Journal:  Nature       Date:  1967-12-30       Impact factor: 49.962

10.  Reagin-like antibodies in rats infected with the nematode parasite Nippostrongylus brasiliensis.

Authors:  B M Ogilvie
Journal:  Immunology       Date:  1967-02       Impact factor: 7.397
View more
  8 in total

1.  Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.

Authors:  E S Assem; A W Richter
Journal:  Immunology       Date:  1971-11       Impact factor: 7.397

2.  Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins.

Authors:  J S Cox; T S Orr; M C Pollard; J Gwilliam
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

3.  Antigen-induced hypersensitivity of the bronchial system and the influence of disodium cromoglycate.

Authors:  I Zimmermann; W T Ulmer
Journal:  Pneumonologie       Date:  1976-04-09

4.  Studies on the role of the mast cell in local calcergy.

Authors:  J McClure
Journal:  Experientia       Date:  1980-06-15

5.  Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. II. A comparison of the rat anti-dnp 7S 2 and rat reagin induced cutaneous reactions.

Authors:  T S Orr; J Gwilliam; J S Cox
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

6.  Homologous passive cutaneous anaphylaxis (PCA) in mice and heterologous PCA induced in rats with mouse IgE.

Authors:  F Braga; I Mota
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

7.  Pharmacology of bovine pulmonary vein anaphylaxis in vitro.

Authors:  P Eyre
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

Review 8.  Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.